Showing results (181-190 of 251) with videos related to

Sort By:
Pageof 26
Clinical Lung Cancer|March 25, 2020
Association Between Clinical Tumor Burden and Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung CancerTaichi Miyawaki, Hirotsugu Kenmotsu, Keita Mori, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 29, 2014
Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancerMadoka Kimura, Tateaki Naito, Hirotsugu Kenmotsu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2014
Multiplexed molecular profiling of lung cancer using pleural effusionHiroaki Akamatsu, Yasuhiro Koh, Hirotsugu Kenmotsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Three-Year Follow-Up of an Alectinib Phase I/II Study in ALK-Positive Non-Small-Cell Lung Cancer: AF-001JPTomohide Tamura, Katsuyuki Kiura, Takashi Seto, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 22, 2021
Impact of weight loss on treatment with PD-1/PD-L1 inhibitors plus chemotherapy in advanced non-small-cell lung cancerTaichi Miyawaki, Tateaki Naito, Michitoshi Yabe, et al.
Thoracic Cancer|May 30, 2024
Treatment patterns and clinical outcomes of resectable clinical stage III non-small cell lung cancer in a Japanese real-world setting: Surgery cohort analysis of the SOLUTION studyMasahiro Tsuboi, Haruyasu Murakami, Hideyuki Harada, et al.
Cancer Chemotherapy and Pharmacology|April 30, 2017
The incidence and risk factors of febrile neutropenia in chemotherapy-naïve lung cancer patients receiving etoposide plus platinumTakumi Fujiwara, Hirotsugu Kenmotsu, Tateaki Naito, et al.
International Journal of Clinical Oncology|June 28, 2018
Changes in programmed death ligand 1 expression in non-small cell lung cancer patients who received anticancer treatmentsShota Omori, Hirotsugu Kenmotsu, Masato Abe, et al.
The Lancet. Respiratory Medicine|November 10, 2016
Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trialKiyotaka Yoh, Takashi Seto, Miyako Satouchi, et al.
Investigational New Drugs|March 5, 2020
Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancerHiroto Inoue, Akira Ono, Takanori Kawabata, et al.
Pageof 26